Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | PER2 | O15055 | 4/20 | 0.38 |
| ▸ | CRY2 | Q49AN0 | 3/20 | 0.36 |
| ▸ | KCNK3 | O14649 | 6/20 | 0.35 |
| ▸ | USP14 | P54578 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31486876 | 0.87 | KMT2A (0.40) | PER2CRY2KCNK3USP14GAA | |
| SCHEMBL31487339 | 0.85 | HTR2A (0.59) | HTR2AHTR2C | |
| SCHEMBL31486773 | 0.82 | HTR2A (0.47) | HTR2AHTR2CPER2CRY2GAA | |
| Trifluoroacetic Acid SCHEMBL31486790 | 0.76 | HTR3A (0.52) | — | |
| SCHEMBL31487078 | 0.71 | PER2 (0.38) | PER2CRY2KCNK3NPY5R | |
| SCHEMBL31487330 | 0.70 | KMT2A (0.57) | PER2CRY2USP14GAAMAPK1 | |
| SCHEMBL31486982 | 0.70 | HTR2A (0.42) | HTR2AHTR2C | |
| SCHEMBL31486817 | 0.70 | KMT2A (0.57) | PER2CRY2USP14GAAMAPK1 | |
| SCHEMBL31486983 | 0.68 | KMT2A (0.40) | PER2CRY2GAANPY5RMAPK1 | |
| SCHEMBL18202161 | 0.68 | PER2 (0.41) | HTR2AHTR2CPER2CRY2KCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025077825-A1 | METHODS AND COMPOSITIONS FOR TREATING CARDIO-PULMONARY DISORDERS | FAUNA BIO INCORPORATED (US) | 2025-04-17 | — | — | WO | disclosed |